Eagle Rock Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46M Sell
6,785
-77
-1% -$26.4K 0.3% 65
2026
Q1
$2.41M Sell
6,862
-115
-2% -$41K 0.35% 67
2025
Q4
$2.28M Hold
6,977
0.32% 67
2025
Q3
$1.97M Hold
6,977
0.29% 74
2025
Q2
$1.95M Sell
6,977
-25
-0.4% -$7.08K 0.31% 74
2025
Q1
$2.18M Buy
7,002
+105
+2% +$31K 0.37% 71
2024
Q4
$1.8M Hold
6,897
0.3% 78
2024
Q3
$2.22M Sell
6,897
-90
-1% -$29.4K 0.37% 70
2024
Q2
$2.18M Sell
6,987
-39
-0.6% -$11.5K 0.39% 63
2024
Q1
$2M Buy
7,026
+27
+0.4% +$7.9K 0.37% 70
2023
Q4
$2.02M Buy
6,999
+5
+0.1% +$1.36K 0.41% 65
2023
Q3
$1.88M Sell
6,994
-25
-0.4% -$6.24K 0.42% 62
2023
Q2
$1.6M Buy
7,019
+689
+11% +$160K 0.34% 72
2023
Q1
$1.53M Buy
6,330
+705
+13% +$173K 0.35% 68
2022
Q4
$1.54M Hold
5,625
0.35% 70
2022
Q3
$1.27M Buy
+5,625
New +$1.36M 0.33% 72

Other funds holding AMGN

Eagle Rock Investment Company's AMGN Position: Q2 2026 in Review

Eagle Rock Investment Company reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $26.4K and leaving 6,785 shares worth $2.46M. The position accounts for 0.3% of the portfolio, ranked #65.

Eagle Rock Investment Company first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Eagle Rock Investment Company held 6,785 shares of Amgen worth $2.46M as of Q2 2026.
  • Eagle Rock Investment Company sold 77 Amgen shares in Q2 2026, an estimated $26.4K.
  • Amgen made up 0.3% of Eagle Rock Investment Company's portfolio in Q2 2026, its #65 holding.
  • Eagle Rock Investment Company first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.